{"691209":{"#nid":"691209","#data":{"type":"news","title":"Moonlight Therapeutics Advances Peanut Allergy Trial","body":[{"value":"\u003Cp\u003EGeorgia Public Broadcasting recently featured Moonlight Therapeutics and its work to advance a new potential treatment for peanut allergies.\u003C\/p\u003E\u003Cp\u003EChildren\u2019s Healthcare of Atlanta is leading the first human clinical trial of the company\u2019s microneedle stamp, which is designed to deliver a precise amount of peanut allergen through the outer layers of the skin. Moonlight Therapeutics President and CEO Samir Patel completed doctoral research at Georgia Tech and co-founded the Atlanta-based biotechnology company to help translate this technology into a potential treatment.\u003C\/p\u003E\u003Cp\u003ERead the full story from Georgia Public Broadcasting.\u003C\/p\u003E","summary":"","format":"limited_html"}],"field_subtitle":[{"value":"Georgia Public Broadcasting highlights the Georgia Tech-connected company\u2019s first human clinical trial."}],"field_summary":[{"value":"\u003Cp\u003EGeorgia Public Broadcasting recently featured Moonlight Therapeutics and its first human clinical trial for a potential peanut allergy treatment. Co-founded by Georgia Tech alumnus Samir Patel, the Atlanta-based biotechnology company is advancing a microneedle technology designed to deliver treatment through the skin.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"Moonlight Therapeutics is testing a new microneedle-based approach to treating peanut allergies in a clinical trial led by Children\u2019s Healthcare of Atlanta."}],"uid":"36434","created_gmt":"2026-07-22 17:40:55","changed_gmt":"2026-07-22 17:41:45","author":"lcameron30","boilerplate_text":"","field_publication":"","field_article_url":"","location":"Atlanta, GA","dateline":{"date":"2026-07-13T00:00:00-04:00","iso_date":"2026-07-13T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"related_links":[{"url":"https:\/\/www.gpb.org\/news\/2026\/07\/13\/childrens-healthcare-of-atlanta-leads-multi-site-clinical-trials-for-peanut-allergy","title":"Read the full story from Georgia Public Broadcasting"}],"groups":[{"id":"655285","name":"GT Commercialization"}],"categories":[{"id":"138","name":"Biotechnology, Health, Bioengineering, Genetics"},{"id":"139","name":"Business"},{"id":"135","name":"Research"}],"keywords":[{"id":"195134","name":"go-quadranti"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[],"email":[],"slides":[],"orientation":[],"userdata":""}}}